For example, miR-15b, which is down-regulated in pre-treatment high risk cases here, has previously been shown to play a role in the development of multi-drug resistance in gastric cancer cells through up-regulation of the Bcl2 protein and consequent modulation of apoptotic pathways [20]. The gene discussed is BCL2; the disease is gastric cancer.